Skip to content

Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department

Caracterisation of SARS-Cov2 Infected Patients Hospitalized in Infectious Disease Department

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04779021
Enrollment
1300
Registered
2021-03-03
Start date
2020-02-15
Completion date
2022-12-31
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, SARS-CoV Infection

Brief summary

The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.

Interventions

OTHERHospitalisation for SARS-COV2 infection

Patients hospitalized for SARS-COV2 infection

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> or = to 18 * Patients hospitalised for SARS-CoV-2 infection confirmed by RT PCRand/or CT scan and/or serology

Exclusion criteria

* Patients for whom SARS-CoV-2 infection has not been confirmed

Design outcomes

Primary

MeasureTime frameDescription
Clinical characteristics34 monthsDescribe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Biological characteristics34 monthsDescribe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Radiological characteristics34 monthsDescribe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity

Secondary

MeasureTime frameDescription
ICU Length of Stay (LOS)34 monthsDuration measured in days
Number of patient hospitalised for Covid-1934 monthsInpatient up to Day 28 or discharge
Biological tests34 monthsDosage of Lymphocytes, C-reactive protein and IL-6
Evolution of patient general state during hospitalisation34 monthsthe different measures (Body Mass Index (BMI), respiratory rate at rest, peripheral oxygen saturation, need for oxygen supplementation, body temperature) will be aggregated in order to obtain a clinical status corresponding to the clinical evolution (good or bad) of the patient's general state.
Overall Inpatient Mortality34 monthsNumber of death due to Covid-19
Requirement for mechanical ventilation34 monthsNumber of patients requiring mechanical ventilation

Countries

France

Contacts

Primary ContactMichel CARLES
carles.m@chu-nice.fr+33492035847
Backup ContactElisa DEMONCHY
demonchy.e@chu-nice.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026